Cargando…

Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan

End-stage renal disease (ESRD) patients are mostly managed with maintenance hemodialysis (MHD). ESRD patients on MHD also present with many complications, such as anemia, hyperparathyroidism, and hepatitis prevalence. This study depicts the real-world scenario of anemia among MHD and end-stage renal...

Descripción completa

Detalles Bibliográficos
Autores principales: Bukhari, Humera, Ahmad, Aneeqa, Noorin, Amna, Khan, Aimal, Mushtaq, Mehwish, Naeem, Aamir, Iqbal, Muhammad Rashid, Naureen, Faiza, Shah, Yasar, Qayyum, Ahad, Munib, Syed, Azhar, Amer, Ullah, Farman, Khan, Faris Farooq Saeed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940945/
https://www.ncbi.nlm.nih.gov/pubmed/36815007
http://dx.doi.org/10.1155/2023/7418857
_version_ 1784891178589618176
author Bukhari, Humera
Ahmad, Aneeqa
Noorin, Amna
Khan, Aimal
Mushtaq, Mehwish
Naeem, Aamir
Iqbal, Muhammad Rashid
Naureen, Faiza
Shah, Yasar
Qayyum, Ahad
Munib, Syed
Azhar, Amer
Ullah, Farman
Khan, Faris Farooq Saeed
author_facet Bukhari, Humera
Ahmad, Aneeqa
Noorin, Amna
Khan, Aimal
Mushtaq, Mehwish
Naeem, Aamir
Iqbal, Muhammad Rashid
Naureen, Faiza
Shah, Yasar
Qayyum, Ahad
Munib, Syed
Azhar, Amer
Ullah, Farman
Khan, Faris Farooq Saeed
author_sort Bukhari, Humera
collection PubMed
description End-stage renal disease (ESRD) patients are mostly managed with maintenance hemodialysis (MHD). ESRD patients on MHD also present with many complications, such as anemia, hyperparathyroidism, and hepatitis prevalence. This study depicts the real-world scenario of anemia among MHD and end-stage renal disease patients in the Pakistani population. A retrospective, multicentric, and real-world data analytical study was conducted at 4 dialysis centers in Pakistan. The study had a sample size of n = 342 patients on maintenance hemodialysis. The data were gathered from the medical records of patients. Data analysis was performed using STATA Version 16. Statistical significance was gauged at a 0.05 level of significance. According to our results, the mean age of the patients was 45 (±15) years. Most of the patients were male (n = 234, 68.4%), whereas 58.1% of the patients were maintained on twice-weekly hemodialysis. The most commonly reported comorbidities were hypertension and diabetes mellitus. The frequency of dialysis (P < 0.01) and comorbidities (P = 0.009) had a significant association with anemia in MHD patients. The majority of the patients had hyperparathyroidism (52%) with anemia. Upon performing binary logistic regression, multivariate analysis displayed a similar odds value for having anemia in patients with every additional month in the duration of hemodialysis (OR 1.01, P = 0.001), the odds of anemic patients having a positive antihepatitis-C antibody (OR 2.22, P = 0.013), and the odds of having anemia in patients in the age category below 45 years (OR 1.93, P = 0.013). In conclusion, the study results depict that every additional month in the duration of hemodialysis, age (<45 years), and positive anti-HCV antibody status, these variables were more likely to have anemia in our study MHD patients. While in our final multivariate model, no statistically significant association was observed between hyperparathyroidism and anemia.
format Online
Article
Text
id pubmed-9940945
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-99409452023-02-21 Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan Bukhari, Humera Ahmad, Aneeqa Noorin, Amna Khan, Aimal Mushtaq, Mehwish Naeem, Aamir Iqbal, Muhammad Rashid Naureen, Faiza Shah, Yasar Qayyum, Ahad Munib, Syed Azhar, Amer Ullah, Farman Khan, Faris Farooq Saeed Int J Clin Pract Research Article End-stage renal disease (ESRD) patients are mostly managed with maintenance hemodialysis (MHD). ESRD patients on MHD also present with many complications, such as anemia, hyperparathyroidism, and hepatitis prevalence. This study depicts the real-world scenario of anemia among MHD and end-stage renal disease patients in the Pakistani population. A retrospective, multicentric, and real-world data analytical study was conducted at 4 dialysis centers in Pakistan. The study had a sample size of n = 342 patients on maintenance hemodialysis. The data were gathered from the medical records of patients. Data analysis was performed using STATA Version 16. Statistical significance was gauged at a 0.05 level of significance. According to our results, the mean age of the patients was 45 (±15) years. Most of the patients were male (n = 234, 68.4%), whereas 58.1% of the patients were maintained on twice-weekly hemodialysis. The most commonly reported comorbidities were hypertension and diabetes mellitus. The frequency of dialysis (P < 0.01) and comorbidities (P = 0.009) had a significant association with anemia in MHD patients. The majority of the patients had hyperparathyroidism (52%) with anemia. Upon performing binary logistic regression, multivariate analysis displayed a similar odds value for having anemia in patients with every additional month in the duration of hemodialysis (OR 1.01, P = 0.001), the odds of anemic patients having a positive antihepatitis-C antibody (OR 2.22, P = 0.013), and the odds of having anemia in patients in the age category below 45 years (OR 1.93, P = 0.013). In conclusion, the study results depict that every additional month in the duration of hemodialysis, age (<45 years), and positive anti-HCV antibody status, these variables were more likely to have anemia in our study MHD patients. While in our final multivariate model, no statistically significant association was observed between hyperparathyroidism and anemia. Hindawi 2023-02-13 /pmc/articles/PMC9940945/ /pubmed/36815007 http://dx.doi.org/10.1155/2023/7418857 Text en Copyright © 2023 Humera Bukhari et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bukhari, Humera
Ahmad, Aneeqa
Noorin, Amna
Khan, Aimal
Mushtaq, Mehwish
Naeem, Aamir
Iqbal, Muhammad Rashid
Naureen, Faiza
Shah, Yasar
Qayyum, Ahad
Munib, Syed
Azhar, Amer
Ullah, Farman
Khan, Faris Farooq Saeed
Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan
title Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan
title_full Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan
title_fullStr Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan
title_full_unstemmed Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan
title_short Association of Anemia with Parathyroid Hormone Levels and Other Factors in Patients with End-Stage Renal Disease Undergoing Hemodialysis: A Cross-Sectional, Real-World Data Study in Pakistan
title_sort association of anemia with parathyroid hormone levels and other factors in patients with end-stage renal disease undergoing hemodialysis: a cross-sectional, real-world data study in pakistan
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940945/
https://www.ncbi.nlm.nih.gov/pubmed/36815007
http://dx.doi.org/10.1155/2023/7418857
work_keys_str_mv AT bukharihumera associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan
AT ahmadaneeqa associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan
AT noorinamna associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan
AT khanaimal associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan
AT mushtaqmehwish associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan
AT naeemaamir associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan
AT iqbalmuhammadrashid associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan
AT naureenfaiza associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan
AT shahyasar associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan
AT qayyumahad associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan
AT munibsyed associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan
AT azharamer associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan
AT ullahfarman associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan
AT khanfarisfarooqsaeed associationofanemiawithparathyroidhormonelevelsandotherfactorsinpatientswithendstagerenaldiseaseundergoinghemodialysisacrosssectionalrealworlddatastudyinpakistan